Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mar Pollut Bull ; 166: 112187, 2021 May.
Article in English | MEDLINE | ID: mdl-33639379

ABSTRACT

Millions of tons of plastic enter the environment every year, where much of it concentrates in environmental sinks such as tidal marshes. With prior studies documenting harm to marine fauna caused by this plastic pollution, the need to understand how this novel type of pollution affects estuarine fauna is great. Yet, research on the fate and uptake of plastic pollutants in estuarine ecosystems is sparse. Therefore, we quantified plastic prevalence and ingestion by two species of resident marsh bird, Clapper Rails (Rallus crepitans) and Seaside Sparrows (Ammospiza maritima), in coastal marsh ecosystems within Mississippi. We detected microplastics (plastics smaller than 5 mm) in 64% of marsh sediment samples, 83% of Clapper Rail and 69% of Seaside Sparrow proventriculus samples. Dominant types of microplastics detected in sediment and bird samples were fibers. This study provides the first evidence of microplastic ingestion by marsh birds and its distribution in coastal marshes within Mississippi.


Subject(s)
Water Pollutants, Chemical , Wetlands , Animals , Birds , Eating , Ecosystem , Environmental Monitoring , Microplastics , Mississippi , Plastics , Water Pollutants, Chemical/analysis
2.
Vaccine ; 28(12): 2465-71, 2010 Mar 11.
Article in English | MEDLINE | ID: mdl-20064479

ABSTRACT

To evaluate the potential economic value of a Staphylococcus aureus vaccine for pre-operative orthopedic surgery patients, we developed an economic computer simulation model. At MRSA colonization rates as low as 1%, a $50 vaccine was cost-effective [or=30%, and a $100 vaccine at vaccine efficacy >or=70%. High MRSA prevalence (>or=25%) could justify a vaccine price as high as $1000. Our results suggest that a S. aureus vaccine for the pre-operative orthopedic population would be very cost-effective over a wide range of MRSA prevalence and vaccine efficacies and costs.


Subject(s)
Methicillin-Resistant Staphylococcus aureus/immunology , Preoperative Care/economics , Preoperative Care/methods , Staphylococcal Infections/prevention & control , Staphylococcal Vaccines/economics , Staphylococcal Vaccines/immunology , Surgical Wound Infection/prevention & control , Cost-Benefit Analysis , Humans , Models, Statistical , Orthopedics , Staphylococcal Infections/economics , Surgical Wound Infection/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...